This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Teleflex Yönetim

Yönetim kriter kontrolleri 2/4

Teleflex CEO'su Liam Kelly, May2016 tarihinde atandı, in görev süresi 6.5 yıldır. in toplam yıllık tazminatı $ 8.67M olup, şirket hissesi ve opsiyonları dahil olmak üzere 11.3% maaş ve 88.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.038% ine doğrudan sahiptir ve bu hisseler € 3.66M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.6 yıl ve 5.8 yıldır.

Anahtar bilgiler

Liam Kelly

İcra Kurulu Başkanı

US$8.7m

Toplam tazminat

CEO maaş yüzdesi	11.3%
CEO görev süresi	6.5yrs
CEO sahipliği	0.04%
Yönetim ortalama görev süresi	2.6yrs
Yönetim Kurulu ortalama görev süresi	5.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Liam Kelly'un ücretlendirmesi Teleflex'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 25 2022	n/a	n/a	US$412m
Jun 26 2022	n/a	n/a	US$510m
Mar 27 2022	n/a	n/a	US$488m
Dec 31 2021	US$9m	US$982k	US$485m
Sep 26 2021	n/a	n/a	US$434m
Jun 27 2021	n/a	n/a	US$351m
Mar 28 2021	n/a	n/a	US$280m
Dec 31 2020	US$6m	US$943k	US$336m
Sep 27 2020	n/a	n/a	US$367m
Jun 28 2020	n/a	n/a	US$479m
Mar 29 2020	n/a	n/a	US$551m
Dec 31 2019	US$7m	US$869k	US$462m
Sep 29 2019	n/a	n/a	US$442m
Jun 30 2019	n/a	n/a	US$269m
Mar 31 2019	n/a	n/a	US$183m
Dec 31 2018	US$6m	US$846k	US$196m
Sep 30 2018	n/a	n/a	US$66m
Jul 01 2018	n/a	n/a	US$89m
Apr 01 2018	n/a	n/a	US$170m
Dec 31 2017	US$3m	US$617k	US$155m
Oct 01 2017	n/a	n/a	US$259m
Jul 02 2017	n/a	n/a	US$246m
Apr 02 2017	n/a	n/a	US$227m
Dec 31 2016	US$3m	US$581k	US$237m
Sep 25 2016	n/a	n/a	US$267m
Jun 26 2016	n/a	n/a	US$262m
Mar 27 2016	n/a	n/a	US$248m
Dec 31 2015	US$3m	US$532k	US$236m

Tazminat ve Piyasa: Liam 'nin toplam tazminatı ($USD 8.67M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 4.76M ).

Tazminat ve Kazançlar: Liam şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.

CEO

Liam Kelly (55 yo)

6.5yrs

Görev süresi

US$8,673,634

Tazminat

Mr. Liam J. Kelly has been Chief Executive Officer at Teleflex Incorporated since January 01, 2018 and has been its Director since May 4, 2018. He serves as Independent Director of Enovis Corporation (form...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Liam Kelly	Chairman	6.5yrs	US$8.67m	0.038% € 3.7m
Thomas Powell	Executive VP & CFO	10.7yrs	US$3.48m	0.021% € 2.0m
Cameron Hicks	Corporate VP & Chief Human Resources Officer	9.6yrs	US$1.48m	0.015% € 1.4m
Jay White	Corporate VP & President of Global Commercial	1.8yrs	US$1.99m	0.0063% € 607.8k
James Winters	Corporate VP	no data	US$1.35m	0.0014% € 131.1k
John Deren	Corporate VP & Chief Accounting Officer	5.5yrs	Veri yok	0.0027% € 263.1k
John Hsu	Vice President of Investor Relations	no data	Veri yok	Veri yok
Daniel Logue	Corporate VP	1.8yrs	Veri yok	0.019% € 1.8m
Howard Cyr	Corporate VP & Chief Compliance Officer	less than a year	Veri yok	Veri yok
Matt Tomkin	Vice President of Corporate Development	less than a year	Veri yok	Veri yok
Michelle Fox	Corporate VP & Chief Medical Officer	2.8yrs	Veri yok	Veri yok
Matthew James	President	2.4yrs	Veri yok	Veri yok

2.6yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: TBH 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.6 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Liam Kelly	Chairman	4.5yrs	US$8.67m	0.038% € 3.7m
George Babich	Independent Lead Director	17.6yrs	US$333.15k	0.024% € 2.4m
John Heinmiller	Independent Director	3.8yrs	US$275.31k	0.0052% € 500.0k
Gretchen Frances Haggerty	Independent Director	6.2yrs	US$276.31k	0.0068% € 658.2k
Richard Packer	Independent Director	5.5yrs	US$274.31k	0.0064% € 623.3k
Stuart Randle	Independent Director	13.5yrs	US$295.31k	0.0084% € 811.6k
Andrew Krakauer	Independent Director	4.8yrs	US$274.38k	0.0075% € 732.0k
Stephen Klasko	Independent Director	14.5yrs	US$274.45k	0.020% € 1.9m
Candace Duncan	Independent Director	7.5yrs	US$300.81k	0.0066% € 641.7k
Neena Patil	Independent Director	less than a year	Veri yok	Veri yok

5.8yrs

Ortalama Görev Süresi

66.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TBH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.8 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2022/11/16 08:16
Gün Sonu Hisse Fiyatı	2022/08/19 00:00
Kazançlar	2022/09/25
Yıllık Kazançlar	2021/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Teleflex Incorporated 35 Bu analistlerden 15, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Ishan Majumdar	Baptista Research
Matthew Taylor	Barclays
Craig Bijou	BofA Global Research

This company listing is no longer active

Teleflex Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Teleflex Incorporated, Annual General Meeting, May 03, 2024

Insufficient new directors

Teleflex Incorporated, Annual General Meeting, Apr 29, 2022

Teleflex Incorporated Announces Board Changes

Insufficient new directors

Independent Director recently bought €273k worth of stock

Recent updates

Teleflex Incorporated Revises Earnings Guidance for the Full Year 2024

Teleflex Incorporated Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray

Teleflex Incorporated Announces Quarterly Cash Dividend, Payable on June 14, 2024

Teleflex Incorporated Raises Earnings Guidance for the Full Year 2024

Teleflex Incorporated, Annual General Meeting, May 03, 2024

Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024

Teleflex Incorporated Offers Its Titan SGS Stapler with Staple Line Reinforcement

Teleflex Incorporated Announces First Patient Enrollment in ACCESS-MANTA Registry

Teleflex Incorporated Announces A New Peer-Reviewed Study in the Nature Journal Prostate Cancer and Prostatic Diseases Confirms the Position of the UroLift System as the Gold Standard in Minimally Invasive Surgical Treatment

Teleflex Incorporated Provides Earnings Guidance for the Full Year 2023

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Teleflex Incorporated Announces Extension of Arrow ErgoPack Complete System to Hemodialysis and Large Bore Central Venous Catheters

Teleflex Incorporated Updates Earnings Guidance for the Year 2023

Teleflex Incorporated Receives FDA Clearance for Expanded Indication for QuikClot Control+(TM) Hemostatic Device Usage in Cardiac Surgical Procedures

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB for $650 million.

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB from Östersjöstiftelsen, Endowment Arm, Praktikerinvest AB and Recipharm Venture Fund AB for $650 million.

Teleflex Incorporated Receives FDA Clearance for the Wattson Temporary Pacing Guidewire

Teleflex Incorporated Announces the Arrow(R) EZ-Io(R) Needle Is Now FDA Cleared for Use in an MRI Environment

Teleflex Announces Quarterly Dividend, June 15, 2023

Teleflex Incorporated Provides Earnings Guidance for the Year 2023

Teleflex Incorporated Announces Worldwide Recall of Affected Lots of Gibeck Iso-Gard Filter Products

Teleflex Incorporated Revises Earnings Guidance for the Year 2022

Teleflex Incorporated (NYSE:TFX) completed the acquisition of Standard Bariatrics, Inc.

Teleflex Incorporated Launches New Arrow® Pressure Injectable Midline Catheter Portfolio

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Standard Bariatrics, Inc. for $300 million.

Upcoming dividend of US$0.34 per share

Second quarter 2022 earnings released: EPS: US$2.25 (vs US$1.78 in 2Q 2021)

Teleflex Incorporated Provides Earnings Guidance for the Full Year of 2022

Teleflex Incorporated (NYSE:TFX) acquired unknown stake in Traverse Vascular Inc.

Teleflex Incorporated Announces First Patient Enrollment in MANTA Ultra Study

Teleflex Launches New Arrow Pressure Injectable Midline Catheter in Australia and New Zealand

Teleflex Incorporated Launches New Arrow Pressure Injectable Midline Catheter in Europe, the Middle East and Africa Region

Teleflex Incorporated Reaffirms Earnings Guidance for the Full Year of 2022

Teleflex Incorporated Announces Regulatory Clearance for Its Urolift® System in China for the Treatment of Benign Prostatic Hyperplasia

Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device

Teleflex Incorporated Declares Quarterly Cash Dividend, Payable on June 15, 2022

First quarter 2022 earnings released: EPS: US$1.65 (vs US$1.60 in 1Q 2021)

Insufficient new directors

Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia

Teleflex Incorporated, Annual General Meeting, Apr 29, 2022

Teleflex Incorporated Announces Board Changes

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Teleflex Incorporated Declares Quarterly Cash Dividend, Payable March 15, 2022

Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures

Insufficient new directors

Independent Director recently bought €273k worth of stock

Upcoming dividend of US$0.34 per share

Third quarter 2021 earnings released: EPS US$4.26 (vs US$2.51 in 3Q 2020)

Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarged Prostate Procedures At the American Urological Association 2021 Annual Meeting

Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2 System

Teleflex Incorporated Announces New Study Provides Insights into the Biocompatibility and Durability of the UroLiftSystem in Improving Benign Prostatic Hyperplasia Symptoms

Upcoming dividend of US$0.34 per share

Second quarter 2021 earnings released: EPS US$1.78 (vs US$0.25 in 2Q 2020)

Medline Industries, Inc. completed the acquisition of Certain product lines of global respiratory product portfolio of Teleflex Incorporated.

Medline Industries, Inc. entered into a definitive agreement to acquire Certain product lines of global respiratory product portfolio from Teleflex Incorporated (NYSE:TFX) for approximately $270 million.

Upcoming dividend of US$0.34 per share

Teleflex Incorporated Declares Quarterly Cash Dividend, Payable on June 15, 2021

First quarter 2021 earnings released: EPS US$1.60 (vs US$2.83 in 1Q 2020)

Teleflex Incorporated Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System

Full year 2020 earnings released: EPS US$7.22 (vs US$10.00 in FY 2019)

Revenue beats expectations

Teleflex Incorporated Announces Submission of Biologics License Application for its Investigational Freeze Dried Plasma

Teleflex Incorporated Completes Enrollment in CTO-PCI IDE Study

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat